Condition
Dry Eyes Chronic
Total Trials
6
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
50%
3 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
6Total
Not Applicable (1)
Early P 1 (1)
P 1 (1)
P 3 (1)
P 4 (2)
Trial Status
Not Yet Recruiting3
Withdrawn2
Completed1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT06903611Phase 3Not Yet Recruiting
Phase III Study of Topical Fibrinogen-Depleted Human Platelet Lysate Compared to Placebo for Moderate to Severe Dry Eye
NCT07267481Phase 4Not Yet Recruiting
Switching From Xiidra to TRYPTYR
NCT06379685Phase 1Not Yet Recruiting
Study to Evaluate the Safety and Tolerability of PRO-190 Ophthalmic Solution Compared to Systane Ultra® on the Ocular Surface.
NCT05169931Early Phase 1WithdrawnPrimary
Clinical Efficacy of Amniotic Membrane Extract Eye Drops in Dry Eye Treatment
NCT03952481Phase 4Withdrawn
Effect of Lifitegrast 5% on Tear Film Markers
NCT03089580Not ApplicableCompletedPrimary
Intense Pulsed Light Study for Dry Eye Disease
Showing all 6 trials